### RNU6-23P Gene Overview

**Gene Symbol:** RNU6-23P  
**Type:** This gene is classified as a small nucleolar RNA (snoRNA). It is a pseudogene, which means it may have lost the function of encoding a protein.

### 1. Associated Genes
RNU6-23P is part of a family of snoRNAs, particularly those involved in the modification and processing of ribosomal RNA (rRNA). While specific genes directly associated with RNU6-23P may not be extensively mentioned in broad databases like NCBI or UniProt, snoRNAs in general are often involved in complex interactions with various ribosomal genes, rRNA genes, and additional small RNAs. Other snoRNAs include:

- **RNU6-1**: A well-studied U6 snRNA involved in pre-mRNA splicing.
- **RNU6-2**: Another member of the U6 family of snoRNAs.
- **RNU6-5 and RNU6-22**: Other snoRNAs that may exhibit interaction through shared biogenesis pathways.

### 2. Aging or Age-related Diseases
There is growing evidence that alterations in the expression of snoRNAs, including pseudogenes like RNU6-23P, may play a role in cellular aging and age-related diseases. Changes in the regulation of snoRNA can impact ribosome biogenesis and overall cell function, thus potentially contributing to age-related decline and diseases like cancer. Although specific studies on RNU6-23P in the context of aging are limited, snoRNAs, in general, are often linked to processes such as:

- **Cellular senescence**: Where there is an accumulation of expression changes in snoRNAs.
- **Cancer mechanisms**: Dysregulation of snoRNAs may contribute to tumorigenesis.

### 3. Drug Interactions
As RNU6-23P is a pseudogene encoding snoRNA, direct interactions with specific drugs or drug classes are not typically documented in existing literature. However, general interactions that affect RNA biogenesis or splicing could indirectly influence the activity of snoRNAs. For example:

- **Antisense oligonucleotides (ASOs)**: These can target specific RNA species for degradation and might affect the regulatory dynamics of snoRNA expression.
- **Drugs used in cancer therapy**: Drugs impacting RNA biogenesis may indirectly alter snoRNA function, although specific drug classes may not be exclusively identified for RNU6-23P.

### 4. Pathways and Biological Processes
RNU6-23P is primarily involved in the following biological processes:

- **Small nucleolar RNA (snoRNA) function**: Primarily participates in the modification of rRNA and is critical in ribosome assembly and function.
- **Pre-mRNA splicing**: Although RNU6-23P is a pseudogene, snoRNAs generally are known to work alongside snRNPs in the spliceosome complex.
- **Gene regulation**: Implications in regulating the expression of target genes through small RNA pathways, primarily in conditions where abnormally expressed snoRNAs might influence overall gene expression.

### Summary
The RNU6-23P gene is a snoRNA pseudogene that plays a role in various cellular processes, particularly involving RNA modification and splicing. Its direct associations with aging, drug interactions, and pathways remain areas of emerging research, highlighting the importance of understanding snoRNA in both normal and pathological conditions.